- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- N-(6-(2-aminophenylamino)-6-oxohexyl)-4-methylbenzamide
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
N-(6-(2-aminophenylamino)-6-oxohexyl)-4-methylbenzamide
| EU orphan designation number: | EU/3/10/793
|
| Active ingredient: | N-(6-(2-aminophenylamino)-6-oxohexyl)-4-methylbenzamide |
| Indication: | Treatment of Friedreich's ataxia |
| Sponsor: | Repligen Europe Limited
25/28 North Wall Quay, Dublin 1, Dublin Co., Ireland |
Public summary of scientific opinion
European Commission procedures |
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 06/10/2010 | Orphan designation | EMA/OD/026/10 | (2010)6938 of 01/10/2010 |
CONTACT
EU links
Directorate General Health & Consumers